日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

TCM soup can help cut COVID-19 death rate of patients in half, study shows

By WANG XIAOYU | CHINA DAILY | Updated: 2021-05-10 09:21
Share
Share - WeChat
Pharmacists dispense medicines according to Qingfei Paidu Soup prescriptions at Anhui University of Chinese Medicine on Feb 21, 2020. [Photo/Xinhua]

Qingfei paidu soup, a widely used traditional Chinese medicine to treat COVID-19 infections, can help reduce the rate of death among hospitalized patients by half, a recent study has shown.

The study examines more than 8,900 COVID-19 cases that received treatment at 15 hospitals in Hubei province-the hardest-hit region during the epidemic-from January to May last year, with nearly 30 percent of them having taken qingfei paidu as part of their therapies.

Results suggest that the mortality rate for those undergoing the TCM treatment stands at 1.2 percent, while the rate for other patients is 4.8 percent.

The study, led by researchers from Fuwai Hospital of the Chinese Academy of Medical Sciences & Peking Union Medical College, concluded that the use of qingfei paidu is associated with a 50 percent reduction of mortality in hospitalized COVID-19 patients, without amplifying the risk of developing acute liver or kidney injuries.

It was first published on preprint website MedRxiv.org in late December. On March 31, it was released on Phytomedicine, a peer-reviewed journal.

Li Jing, head of the research team, said based on the national diagnosis and treatment guideline for COVID-19 diseases, qingfei paidu is the only prescription that is recommended for treating all patients ranging from mild to critical cases.

"The extensive delivery of TCM medication in hospitalized patients during the outbreak had created a sound base for our research because when appraising clinical effectiveness of a certain drug, it is crucial to start by collecting and analyzing from a large enough number of cases," she said.

Qingfei paidu is a concoction that includes dozens of TCM herbs and roots, including ephedra, licorice root and bitter almond. The initial version of the prescription is believed to have originated during the Eastern Han Dynasty (25-220).

Zhang Boli, president of the Tianjin University of Traditional Chinese Medicine, said during an earlier interview that preliminary studies show the therapy mainly works on lungs while offering protection for some other organs against the virus. It can also stem the virus's replication, Zhang said.

According to the National Administration of Traditional Chinese Medicine, previous studies have already attested to the herbal prescription's efficacy in preventing mild and moderate cases from worsening into severe infections, but evidence of its role in lowering the death rate was lacking.

"The study is by far the largest clinical research on qingfei paidu and its findings have provided potent evidence for proving its marked efficacy in saving the lives of COVID-19 patients," the administration said.

As of now, there is no approved specific treatment for COVID-19 patients. During the fight against the epidemic, 92 percent of confirmed patients had undergone TCM therapies, with the efficacy rate in Hubei reaching 90 percent, according to a white paper released in June.

Li said the new study is retrospective and based on real-world cases.

"If a randomized, double-blind, placebo-controlled clinical study can be conducted in the future, the TCM drug's clinical efficacy can be further verified, and its global application is expected to expand," she added.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲午夜网站 | 殴美一区| 蜜桃传媒一区二区亚洲AV | 毛片91 | 一区二区日韩精品 | 久久人 | 日韩影院在线观看 | 欧美顶级毛片在线播放 | 久操欧美 | 精品欧美一区二区在线观看 | 性爱视频在线免费 | 成人免费毛片aaaaaa片 | 久久久亚洲伊人色综合网站 | 浮力影院在线观看 | 成人av播放 | 成人在线视频在线观看 | 国产午夜福利视频一区二区32页 | 一区二区三区免费 | 污污视频免费网站 | 夜夜夜爽 | 偷拍亚洲制服另类无码专区 | 我要看真正的免费毛片 | 国内精品久久久久 | 国产视频网站在线观看 | 欧美综合视频在线 | 日本一级在线 | 欧美视频在线免费播放 | 欧美国产精品一区 | 毛片免费观看 | 国产色片在线观看 | 成人午夜影院 | 亚洲 欧美 日韩 综合aⅴ视频 | 草久网| 国产精品自拍99 | 一区二区三区免费视频 www | 久久精品一级 | 国产专区精品 | 亚洲精品无码成人A片在线虐 | 超级碰碰碰频视频免费观看 | 丰满岳妇乱一区二区三区 | 亚洲激情视频网 |